DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Piper Sandler Initiates Coverage On Itamar Medical with Overweight Rating, Announces $22 Price Target

Piper Sandler analyst Matt O'Brien initiates coverage on Itamar Medical (NASDAQ:ITMR) with a Overweight rating and a $22 price target.

Benzinga · 02/05/2020 10:15

Piper Sandler analyst Matt O'Brien initiates coverage on Itamar Medical (NASDAQ:ITMR) with a Overweight rating and a $22 price target.